H3N2 M2SR in Pediatric Population

NCT03553940 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

NIH

Sponsor class

Conditions

Influenza
Influenza Immunisation

Interventions

BIOLOGICAL: Influenza Virus Monovalent A/H3N2/Bris 10 M2SR Live Vaccine
OTHER: Placebo
BIOLOGICAL: Quadrivalent MDCK Inactivated Influenza Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)